Inter- And Intraprovincial Inequities in Public Coverage of Cancer Drug Programs Across Canada: A Plea for the Establishment of a Pan-Canadian Pharmacare Program

Current Oncology - Canada
doi 10.3747/co.26.4867
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

MultiMed Inc.

Related search

Clinician Participation in CADTH’s Pan-Canadian Oncology Drug Review: Contribution and Impact on Cancer Drug Funding Recommendations

Current Oncology
Oncology
2017English

Addressing Health Inequities in Ontario, Canada: What Solutions Do the Public Support?

BMC Public Health
EnvironmentalPublic HealthOccupational Health
2017English

Public Drug Policy for Children in Canada

CMAJ
Medicine
2017English

Informing Canada’s Cancer Drug Funding Decisions With Scientific Evidence and Patient Perspectives: The Pan-Canadian Oncology Drug Review

Current Oncology
Oncology
2013English

Value of a Zero-Copay Drug Program: Implication for Employee Wellness Programs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Impact of the Pan-Canadian Pricing Alliance (Pcpa) on Access to Drug Treatment Options for Canadian Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Accounting for Community Impact: Thinking Across the Spaces and Times of a Seven-Year Pan-Canadian Community-Based Research Project

Michigan Journal of Community Service Learning
2020English

Advancing Early Childhood Development and Prevention Programs: A Pan-Canadian Knowledge Transfer Initiative for Better Beginnings, Better Futures

Australian and New Zealand Journal of Family Therapy
SociologyPsychologyPolitical Science
2018English

Identification of Performance Indicators Across a Network of Clinical Cancer Programs

Current Oncology
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy